Prevalence and predictors of peripheral neuropathy after breast cancer treatment

BACKGROUND: Many of the 3.8 million breast cancer survivors in the United States experience long‐term side effects of cancer therapy including peripheral neuropathy (PN). We assessed the prevalence and predictors of PN among women with breast cancer followed in the Women's Health Initiative...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamgar, Mandana, Greenwald, Mark K., Assad, Hadeel, Hastert, Theresa A., McLaughlin, Eric M., Reding, Kerryn W, Paskett, Electra D., Bea, Jennifer W., Shadyab, Aladdin H., Neuhouser, Marian L., Nassir, Rami, Crane, Tracy E., Sreeram, Kalyan, Simon, Michael S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495292/
https://www.ncbi.nlm.nih.gov/pubmed/34390205
http://dx.doi.org/10.1002/cam4.4202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495292/
https://www.ncbi.nlm.nih.gov/pubmed/34390205
http://dx.doi.org/10.1002/cam4.4202

Ejemplares similares